Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Levalbuterol Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 12,414Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Xopenex

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Xopenex

    Levalbuterol

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Xopenex

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Dainippon Sumitomo

    Levalbuterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 47

    2019 Revenue in Millions : 40

    Growth (%) : 20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Xopenex

    Levalbuterol

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Xopenex

    Japan
    arrow
    Antibody Engineering
    Not Confirmed

    Dainippon Sumitomo

    Levalbuterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2016 Revenue in Millions : 50

    2015 Revenue in Millions : 61

    Growth (%) : -18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Xopenex

    Levalbuterol

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Xopenex

    Japan
    arrow
    Antibody Engineering
    Not Confirmed

    Dainippon Sumitomo

    Levalbuterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2017 Revenue in Millions : 67

    2016 Revenue in Millions : 102

    Growth (%) : -34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Xopenex

    Levalbuterol

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Xopenex

    Japan
    arrow
    Antibody Engineering
    Not Confirmed

    Dainippon Sumitomo

    Levalbuterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2018 Revenue in Millions : 41

    2017 Revenue in Millions : 36

    Growth (%) : 15%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Xopenex

    Levalbuterol

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Xopenex

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Dainippon Sumitomo

    Levalbuterol

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2019 Revenue in Millions : 38

    2018 Revenue in Millions : 43

    Growth (%) : -11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF